IrishAngels Fund Management LLC – Trademark Portfolio
Entity Type: 16
IrishAngels Fund Management LLC holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include VITALIZEVC and VIA FOR FOUNDERS. The owner is based in Chicago, IL.
#504B
415 N. LaSalle Dr.
Chicago, IL 60654
Showing of trademarks Trademarks
Trademark Classifications
IrishAngels Fund Management LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does IrishAngels Fund Management LLC have?
IrishAngels Fund Management LLC has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does IrishAngels Fund Management LLC file in?
IrishAngels Fund Management LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 36 (Insurance & Financial). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are IrishAngels Fund Management LLC's most well-known trademarks?
IrishAngels Fund Management LLC's registered trademark portfolio includes well-known marks such as VITALIZEVC and VIA FOR FOUNDERS. These are among 2 currently registered trademarks in the portfolio.
What is IrishAngels Fund Management LLC's trademark registration success rate?
IrishAngels Fund Management LLC has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.